"/> Novus Biologicals™ Peptide bloquant d’anticorps MA… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps MADD

Réf. : BL-RE-082521Réf. fabricant : 18218605 0.05 mg
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
8567
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-77033. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide containing 19 amino acids near the carboxy terminus of human MADD.

Points forts

Source

Synthetic

(Accession #: AAD12154) The MADD Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-082521
Réf. fabricant18218605
Gene ID (Entrez)8567
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-77033. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gèneDENNFLJ36300, Differentially expressed in normal and neoplastic cells, FLJ35600, IG20, Insulinoma glucagonoma clone 20, insulinoma-glucagonoma protein 20, KIAA0358RAB3GEP, MAP kinase-activating death domain protein, MAP-kinase activating death domain, Rab3 GDP/GTP exchange factor
Symbole de gène(s)MADD
Type de produitMADD
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne19 amino acids near the carboxy terminus of human MADD
Une question, une configuration particulière ?
Contactez-nous pour un devis.